Followers

Monday, October 31, 2011

FDA Approves Abbott's Xience Prime Drug-Eluting Stent

FDA Approves Abbott's Xience Prime Drug-Eluting Stent Abbott announced today that it had received FDA approval for its Xience Prime everolimus-eluting stent. The cobalt chromium stent is designed to be delivered more easily to complex lesions and will be available in long lengths up to 38 mm. ... FDA Approves Abbott's Xience Prime Drug-Eluting Stent

No comments:

Post a Comment

Popular Posts